Search by Drug Name or NDC
NDC 69452-0265-88 Cetirizine HCl 10 mg/1 Details
Cetirizine HCl 10 mg/1
Cetirizine HCl is a ORAL CAPSULE in the HUMAN OTC DRUG category. It is labeled and distributed by Bionpharma Inc.. The primary component is CETIRIZINE HYDROCHLORIDE.
MedlinePlus Drug Summary
Cetirizine is used to temporarily relieve the symptoms of hay fever (allergy to pollen, dust, or other substances in the air) and allergy to other substances (such as dust mites, animal dander, cockroaches, and molds). These symptoms include sneezing; runny nose; itchy, red, watery eyes; and itchy nose or throat. Cetirizine is also used to treat itching and redness caused by hives. However, cetirizine does not prevent hives or other allergic skin reactions. Cetirizine is in a class of medications called antihistamines. It works by blocking the action of histamine, a substance in the body that causes allergic symptoms. Cetirizine is also available in combination with pseudoephedrine (Sudafed, others). This monograph only includes information about the use of cetirizine alone. If you are taking the cetirizine and pseudoephedrine combination product, read the information on the package label or ask your doctor or pharmacist for more information.
Related Packages: 69452-0265-88Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Cetirizine
Product Information
| NDC | 69452-0265 |
|---|---|
| Product ID | 69452-265_f0ff2942-7718-4f25-e053-2a95a90aa7df |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | Cetirizine HCl |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Cetirizine HCl |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | CAPSULE |
| Route | ORAL |
| Active Ingredient Strength | 10 |
| Active Ingredient Units | mg/1 |
| Substance Name | CETIRIZINE HYDROCHLORIDE |
| Labeler Name | Bionpharma Inc. |
| Pharmaceutical Class | Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA022429 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 69452-0265-88 (69452026588)
| NDC Package Code | 69452-265-88 |
|---|---|
| Billing NDC | 69452026588 |
| Package | 1 BOTTLE, PLASTIC in 1 CARTON (69452-265-88) / 65 CAPSULE in 1 BOTTLE, PLASTIC |
| Marketing Start Date | 2019-05-01 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |